Hyperfine (HYPR) Gross Margin Growth (1y) (2022 - 2026)
Hyperfine (HYPR) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 69.00 |
| 10 | Hyperfine | 89.93 Mn | 45.16 Mn | 1.98 Mn | 146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146.00 |
| Mar 31, 2026 | 938.00 |
| Dec 31, 2025 | 1,531.00 |
| Sep 30, 2025 | 139.00 |
| Jun 30, 2025 | -40.00 |
| Mar 31, 2025 | 23.00 |
| Dec 31, 2024 | -291.00 |
| Sep 30, 2024 | 413.00 |
| Jun 30, 2024 | 695.00 |
| Mar 31, 2024 | -274.00 |
| Dec 31, 2023 | 1,743.00 |
| Sep 30, 2023 | 1,894.00 |
| Jun 30, 2023 | 5,347.00 |
| Mar 31, 2023 | 3,827.00 |
| Dec 31, 2022 | 12,497.00 |
| Sep 30, 2022 | 12,041.00 |
| Jun 30, 2022 | 1,689.00 |
| Mar 31, 2022 | 8,925.00 |